NEUROENDOCRINE TUMOR TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Neuroendocrine Tumor Treatment Market, By Drug Class (Somatostatin Analogs, Chemotherapy, Targeted Therapy, Immunotherapy, Others), By Indication (Gastrointestinal NET, Lung NET, Pancreatic NET, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In: 28 Apr, 2026
Code: CMI129
Page number: 180
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Class
  - Market Snippet, By Indication
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Recent Trends
- Recent Launches and Approvals
- Mergers, Acquisitions, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- PORTER’s Analysis
Global Neuroendocrine Tumor Treatment Market, By Drug Class, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- Somatostatin Analogs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  - Segment Trends
- Chemotherapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  - Segment Trends
- Targeted Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  - Segment Trends
- Immunotherapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  - Segment Trends
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  - Segment Trends
Global Neuroendocrine Tumor Treatment Market, By Indication, 2021– 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- Gastrointestinal NET
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  - Segment Trends
- Lung NET
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  - Segment Trends
- Pancreatic NET
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  - Segment Trends
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  - Segment Trends
Global Neuroendocrine Tumor Treatment Market, By Distribution Channel, 2021– 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  - Segment Trends
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  - Segment Trends
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  - Segment Trends
Global Neuroendocrine Tumor Treatment Market, By Region, 2021–2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 –2033, (US$ Bn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 –2033, (US$ Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 –2033, (US$ Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 –2033, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - Introduction
  - Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 –2033, (US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 –2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 –2033, (US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Pfizer Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Novartis AG
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Ispen
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Advanced Accelerator Applications
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Tarveda Therapeutics
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Progenics Pharmaceuticals, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Hutchison Medipharma Limited
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Dauntless Pharmaceuticals Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Exelixis, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
- Analysts’ Views
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 36 market data tables and 26 figures on “Global Neuroendocrine Tumor Treatment Market” – Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now